Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
Article Abstract:
Patients with hepatitis C who experience a relapse following interferon alpha treatment may benefit from ribavirin in addition to interferon alpha. Researchers randomly assigned 345 such patients to take interferon alpha-2b and ribavirin or interferon alpha-2b alone. After 24 weeks of treatment, 82% of those taking both drugs had no detectable levels of hepatitis C virus in their blood, compared to only 47% of those on interferon alpha-2b alone. Half of those taking both drugs continued to have undetectable virus levels 24 weeks after treatment ended, compared to 5% of those taking interferon alpha-2b alone.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Lamivudine as initial treatment for chronic hepatitis B in the United States
Article Abstract:
The drug lamivudine appears to be beneficial in the treatment of hepatitis B. This drug is most commonly used to treat HIV infection. In a study of 137 patients, 66 were treated with lamivudine for one year and 71 were treated with a placebo, or inactive substance. Lamivudine was more successful in suppressing the hepatitis B virus than the placebo and was more effective in preventing damage to the liver.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
- Abstracts: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury
- Abstracts: A randomized, double-blind trial of prostaglandin E2 gel for cervical ripening and meta-analysis. A prospective randomized study of saline solution amnioinfusion
- Abstracts: The frequency of unrecognized type 2 herpes simplex virus infection among women: implications for the control of genital herpes. part 2
- Abstracts: A Phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus